Cajal Neuroscience is a startup based in the Netherlands, most recent round Series A, 1 tracked investor.
Cajal Neuroscience is a startup based in the Netherlands. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Cajal Neuroscience is a biotechnology company focused on accelerating drug discovery for neurodegenerative diseases. The company integrates human genetics, functional genomics, and advanced microscopy to identify novel therapeutic targets and validate them at an unprecedented scale.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.